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Calcium-dependent activator protein for secretion 1
(CAPS1) plays a distinct role in the priming step of
dense core vesicle (DCV) exocytosis. CAPS1 pre-
mRNA is known to undergo adenosine-to-inosine
RNA editing in its coding region, which results in a
glutamate-to-glycine conversion at a site in its C-ter-
minal region. However, the physiological significance
of CAPS1 RNA editing remains elusive. Here, we
created mutant mice in which edited CAPS1 was
solely expressed. These mice were lean due to
increased energy expenditure caused by physical
hyperactivity. Electrophysiological and biochemical
analyses demonstrated that the exocytosis of DCVs
was upregulated in the chromaffin cells and neurons
of these mice. Furthermore, we showed that edited
CAPS1 bound preferentially to the activated form of
syntaxin-1A, a component of the exocytotic fusion
complex. These findings suggest that RNA editing
regulates DCV exocytosis in vivo, affecting physical
activity.
INTRODUCTION
Post-transcriptional modification is a mechanism by which vast
repertoires of mature RNAs and their proteins are generated
from a single gene. One type of post-transcriptional modification
is adenosine-to-inosine RNA editing, which is catalyzed by
ADAR1 (adenosine deaminase acting on RNA type1) and
ADAR2 inmammals. These enzymes recognize double-stranded
RNAs (dsRNAs) as targets (Behm and O¨hman, 2016; Tomaselli
et al., 2014). It is estimated that more than 85% of transcripts2004 Cell Reports 17, 2004–2014, November 15, 2016 ª 2016 The A
This is an open access article under the CC BY license (http://creativeare edited (Athanasiadis et al., 2004). However, most of the edit-
ing sites are located in non-coding regions such as introns in pre-
mRNAs or non-coding RNAs, including microRNAs, and their
significance has been elucidated only in a limited number of
cases (Kawahara et al., 2007a; Sakurai et al., 2014; Wulff et al.,
2011). In contrast, although editing in coding regions is quite
rare (55 sites [Li et al., 2009]), this modification can generate pro-
teins that are not encoded directly by the genome, given that
the translational machinery interprets inosine as if it were guano-
sine. It has been reported that the properties of neurotransmitter
receptors and ion channels are modulated by amino acid con-
version as a consequence of RNA editing (Bazzazi et al., 2013;
Behm and O¨hman, 2016; Bhalla et al., 2004; Brusa et al., 1995;
Burns et al., 1997; Daniel et al., 2011; Morabito et al., 2010).
However, only a few mouse models exist in which either
edited or unedited proteins are expressed exclusively; these
include the glutamate receptor GluA2 subunit and the serotonin
5-HT2C receptor (Brusa et al., 1995; Kawahara et al., 2008;
Morabito et al., 2010). Therefore, little is known about the signif-
icance of the conversion of amino acid residues as a conse-
quence of RNA editing in mammals.
Calcium-dependent activator protein for secretion 1 (CAPS1)
and CAPS2 are members of the CAPS family, which is involved
in vesicle exocytosis (Parsaud et al., 2013; Speidel et al.,
2003). CAPS proteins play an indispensable role in the secretion
of insulin and neurotransmitters, including catecholamines such
as noradrenaline (NA) and dopamine, by regulating the exocy-
tosis of dense-core vesicles (DCVs). Consequently, CAPS pro-
teins are expressed in selective tissues, such as the pancreas,
adrenal gland, and brain (Speidel et al., 2003, 2005, 2008).
Knockout of CAPS1 in mice induced a reduction in DCV release,
leading to neonatal death soon after birth (Farina et al., 2015;
Speidel et al., 2005), which indicates that CAPS1 is required
for efficient DCV exocytosis. Among the multiple steps required
for exocytosis, CAPS1 promotes the priming reaction, which isuthor(s).
commons.org/licenses/by/4.0/).
Figure 1. The Editing Frequency in CAPS1
mRNA and the Secondary Structure
Required for Editing
(A) Schematic diagram of human CAPS1. RNA
editing in the dense core vesicle-binding domain
(DCVBD) changes the codon for amino acid 1250
from GAG to GIG, which converts the glutamate at
residue 1250 (E1250) to glycine (G). This E/G site is
indicated with a red arrow (see Figure S1A). The
position of each domain is assigned by referring to
the longest isoform (NP_003707.2). C2, coiled-coil
domain; PH, Pleckstrin homology domain; MHD1,
Munc13-homology domain 1.
(B) The editing frequency of CAPS1 and CAPS2
mRNAs in various human tissues (see Figure S1B).
(C) The editing frequency of CAPS1 mRNA in
various mouse tissues extracted from both wild-
type and ADAR2/ mice. Values are displayed as
the mean ± SEM (n = 3, WT and 4, ADAR2/;
unpaired t test, *p < 0.05). n.s., no significance.
(D) Schematic diagram of human chromosomal
DNA encompassing exon 27 to exon 29 of the
CADPS gene, which encodes CAPS1. The E/G
site is designated with an asterisk. ECS, editing
complementary sequence.
(E) The degree of conservation among mammals in
the intronic region that is downstream of exon 28,
which contains the E/G site, was analyzed using
the UCSC genome browser. The regions tran-
scribed to generate the three RNAs (RNA1, RNA2,
and RNA3) that were used for the in vitro editing
assays are shown below the graphs. The location
of the identified ECS is highlighted in blue.
(F) The incomplete double-stranded RNA structure
formed by the sequence around the E/G site (in red)
and the ECS, which is required for CAPS1 RNA
editing, is depicted. The nucleotides that differ be-
tween human and mouse are shown in green. The
locations of an additional 10 editing sites observed
in the in vitro editing assay are shown in orangewith
the appropriate number (see Figure S1C).a required step for the fusion of vesicles with the plasma mem-
brane after docking has occurred (Farina et al., 2015). Membrane
fusion is mediated by the trans-SNARE (Soluble NSF attachment
protein receptor) complex, which is composed of the vesicle
SNARE (v-SNARE) and target membrane SNARE (t-SNARE).
CAPS1 promotes assembly of the trans-SNARE complex for
vesicle exocytosis by binding directly through its C-terminal
region to syntaxin-1, a t-SNARE protein (Hammarlund et al.,
2008; Parsaud et al., 2013). Intriguingly, an RNA editing site
was identified in the human Cadps gene, which encodes
CAPS1, by using massively parallel target capture sequencing
and then comparing the genomic DNA sequence with the
sequence of RNAs from a single individual (Li et al., 2009). The
identified RNA editing site corresponds to a glutamate (E) resi-
due at position 1250 (1252 in mouse) in the C-terminal DCV-
binding domain (DCVBD), which was identified originally as aco
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for NA secretion (Figure 1A; Figure S1A)
(Grishanin et al., 2002). The E residue isnverted to glycine (G) as a consequence of RNA editing, and
is site is thereby termed the E/G site. However, the enzyme
sponsible for the editing, the secondary structure required
r recognition by ADARs, and the physiological significance of
e modification remain undetermined.
In this study, we examined the functional difference between
ited and unedited CAPS1 using cultured cell lines and found
at RNA editing accelerates DCV-mediated catecholamine
cretion. Then, we created a mutant mouse model in which
ited CAPS1 was expressed solely, to evaluate the physiolog-
l significance of CAPS1 RNA editing in vivo. Intriguingly,
ited CAPS1 knockin (KI) mice were leaner and showed higher
ergy expenditure than wild-type mice due to increased phys-
l activity, which was attenuated by the administration of
pamine D2 receptor antagonist. Electrophysiological and
ochemical analyses of the mouse brains and adrenal glandss 17, 2004–2014, November 15, 2016 2005
demonstrated that DCV exocytosis was promoted by the RNA
editing of CAPS1. This increased exocytosis was most likely
due to an enhancement of the priming step through more
efficient binding of edited CAPS1 to the activated form of
syntaxin-1, at least in part.
RESULTS
ADAR1 and ADAR2 Coordinately Catalyze CAPS1 RNA
Editing
To investigate the editing frequency of CAPS1mRNA in vivo, we
first obtained samples of total RNA derived from human tissues.
The editing frequency at the E/G site was approximately 15%–
20% in human spinal cord and brain tissues, regardless of the
region examined (Figure 1B; Figure S1B). In contrast, the fre-
quency was 42% in pancreas and the highest (70%) in the
adrenal gland. The amino acid sequence around the editing
site is conserved between CAPS1 and CAPS2 in mammals (Fig-
ure S1A). However, RNA editing was not detected in CAPS2
mRNA at the site corresponding to the E/G site of CAPS1 in
brain, pancreas, or the adrenal gland (Figure 1B). Next, we exam-
ined the editing frequency of CAPS1mRNA in mouse tissues. In
contrast to the wide range of editing frequencies in human tis-
sues, mouse CAPS1 mRNA was edited at the level of 10%–
20%, regardless of the tissue examined (Figure 1C). No editing
could be observed at embryonic stage E15.5 (Figure 1C), which
indicated that the editing was developmentally regulated. To
determine the enzymes responsible for CAPS1 RNA editing
in vivo, we compared the editing frequency between wild-type
(WT) and ADAR2/ mice (Higuchi et al., 2000; Kawahara
et al., 2007b). The editing level was reduced by 30% and 50%
in cerebral cortex and cerebellum, respectively, in ADAR2/
mice as compared with WT mice, whereas no significant alter-
ation was observed in pancreas or heart (Figure 1C). Although
it is difficult to examine the editing level of CAPS1 mRNA in
ADAR1/ mice due to embryonic lethality (Wang et al., 2000),
this result suggests that ADAR2 is partially responsible for
the editing in the brain, whereas ADAR1 probably plays the
predominant role in editing the E/G site of CAPS1 mRNA.
Identification of the Conserved Secondary Structure
Required for CAPS1 RNA Editing
Given that ADARs bind to dsRNAs, editing in certain exon
regions requires the presence of an editing complementary
sequence (ECS), which is usually located in either an upstream
or downstream intron and forms a partial dsRNA structure
(Gerber and Keller, 2001). To identify the ECS that is indispens-
able for humanCAPS1RNA editing, we examined the conserved
sequences in the intron downstream of exon 28, which contains
the E/G site, and found two candidate regions: one located just
adjacent to exon 28, and the other located approximately 1.5 kb
downstream of the exon (Figures 1D and 1E). To determine
whether either region was the ECS, we prepared RNAs that
contained the candidate regions (RNA1 and RNA2) by in vitro
transcription (Figure 1E) and then performed in vitro editing as-
says with recombinant ADAR1 or ADAR2 protein as described
previously (Kawahara et al., 2007b). We detected no editing
with RNA1. However, when RNA2 was used as the substrate,2006 Cell Reports 17, 2004–2014, November 15, 2016ADAR1 edited the E/G site specifically within the exon,and also
edited four sites in the intron, in a dose-dependent manner (Fig-
ure 1F; Figure S1C). In contrast, ADAR2 edited three adenosines
in the exon and seven in the intron, in addition to editing the E/G
site, in RNA2. We also performed in vitro editing assays with
RNA3, which was slightly shorter than RNA2 and lacked a part
of the candidate ECS region (Figure 1E). The results showed
no editing, regardless of the ADAR used. We further confirmed
that the corresponding sequence was absent in CAPS2 pre-
mRNA, and that the predicted secondary structure was largely
conserved between human and mouse (Figure 1F). Taken
together, these results suggested that the ECS corresponds to
the conserved region located approximately 1.5 kb downstream
of exon 28 (Figures 1D and 1E).
CAPS1 RNA Editing Promotes Catecholamine Secretion
from PC12 Cells
To evaluate the functional differences between the edited and
unedited forms of CAPS1 in cultured PC-12 cells, which are
derived from a pheochromocytoma of the rat adrenal medulla,
we first established a stable cell line in which endogenous
CAPS1 was reduced significantly by the stable expression of
four small hairpin RNAs (shRNAs). We named this cell line
shRNA_All-8 (Figure S2). Using shRNA_All-8 cells, we further
established cell lines that stably expressed either the edited
or unedited form of mCherry-mouse CAPS1 (Figure 2A). The
expression construct for unedited CAPS1 lacked the ECS in
the adjacent intronic region, and thus the resulting pre-mRNA
was not subject to RNA editing in the established cell line. After
confirming that the intracellular localization of edited and uned-
ited CAPS1 did not differ, we monitored the amount of radiola-
beled NA secreted from PC12 cells that solely expressed either
edited or unedited CAPS1 during a period of 1 hr after depolariz-
ing stimulation, as described previously (Parsaud et al., 2013).
The data demonstrated that the cells that expressed edited
CAPS1 secreted more NA than those that expressed unedited
CAPS1 at 15 and 30min post-stimulation, whereas no difference
was observed at 60 min, when the secretion of radiolabeled NA
probably reached the saturation (Figure 2B). These results sug-
gest that edited CAPS1 can facilitate the release of NA more
rapidly than unedited CAPS1.
Mutant Mice in which Edited CAPS1 Is Solely Expressed
Exhibit Leanness
Given that the editing frequency at the E/G site tends to be higher
in humans than in mice (Figures 1B and 1C), the role of edited
CAPS1 might be more limited in mice but expanded during the
course of evolution to become more significant in humans.
Therefore, to investigate the role of CAPS1 RNA editing in vivo,
we created mutant mice in which edited CAPS1 was solely ex-
pressed (edited CAPS1 KI mice) by inserting a point mutation
at the E/G site (GAG / GGG) using the conventional ho-
mologous recombination technique (Figures S3A and S3B). We
confirmed that this mutation did not affect the expression level
of CAPS1 protein (Figure S3C). Homozygous edited CAPS1 KI
(KI) mice were born with normal body weight but demonstrated
a significant decrease in growth rate from 4 weeks after birth
(Figure 3A). This reduction in body weight was sustained until
Figure 2. CAPS1 RNA Editing Promotes
Secretion of Noradrenaline from PC12
Cells
(A) Stable cell lines expressing either un-
edited or edited mCherry-mCAPS1 were
established using shRNA_All-8 PC12 cells,
in which endogenous CAPS1 was strongly
knocked down (see Figure S2). The expression
of exogenous mCherry-mCAPS1 was confirmed
by western blot analysis using an anti-CAPS1
antibody in two lines (designated as 1 and 2)
for the unedited and two for the edited forms.
The expression of GAPDH is shown as a
reference.
(B) The percentage efficiency of noradrenaline
(NA) release from the cells expressing either
unedited or edited mCherry-mCAPS1 was measured at 15, 30, and 60 min after stimulation with high K+ buffer. Values are displayed as the
mean ± SEM (ten trials for each line; unpaired t test, *p < 0.05). n.s., no significance; NS, no stimulation.adulthood, regardless of sex, with no difference in body length
between KI and WT littermates. Male KI mice were approxi-
mately 20% leaner than their WT littermates at 12 weeks of
age (Figures 3B and 3C; Figures S3D and S3E). Of note, hetero-
zygous KI mice exhibited moderate leanness, which suggests
that the level of CAPS1 RNA editing was correlated positively
with the severity of the lean phenotype (Figure S3F). This lean-
ness was attributed to a specific reduction in fat accumulation
in white adipose tissue accompanied by a low concentration of
plasma cholesterol (Figures 3D and 3E).
To investigate the cause of the lean phenotype of edited
CAPS1 KI mice, we quantified metabolic rates by measuring ox-
ygen consumption. Energy expenditure in KI micewas increased
significantly as compared with WT mice during both light and
dark periods (Figure 4A). In contrast, we could detect no signifi-
cant alteration in food or water intake, or daily urine output
(Figures 4B–4D). These results suggest that the leanness of edi-
ted CAPS1 KI mice was not due to hypophagia or dehydration,
but rather due to increased energy expenditure. In addition,
the expression levels of mitochondrial Uncoupled protein-1
(UCP-1) mRNA in brown adipose tissue and body temperature
were not significantly different between edited CAPS1 KI and
WT mice (Figures 4E and 4F). Therefore, the increased energy
expenditure could not be attributed to excess wastage through
nonshivering thermogenesis in brown adipose tissue.
Increased Physical Activity in Edited CAPS1 KI Mice
Next, we examined whether the increased energy expenditure
was caused by an alteration in physical activity. As expected,
the total locomotion counts of WT mice in the new environment
decreased gradually during the 3 days tested, which suggests
that the mice were habituated (Figure 5A). In contrast, the activity
of KI mice did not decreased even after habituation. Next, we
quantifieddaily activityafter habituation. The total physical activity
of KI mice was significantly higher than that ofWT during both the
dark and light cycles (Figure 5B). This hyperactive phenotypewas
attenuated by the administration of haloperidol, a dopamine D2
receptor antagonist (Figure 5C). In accordance, energy expendi-
ture in KI mice was also reduced to the level of WT mice by the
administration of haloperidol (Figure 5D). We could not detect
any abnormalities in muscle strength, anxiety-related behavior,pain sensation, space perception, or short- or long-termmemory
as measured by the results of the wire hang test, elevated plus
maze test, hot plate test, water maze learning test, Y maze test,
and passive avoidance test (Figures S4A–S4F). Furthermore, we
found no difference in the urinary concentration of catecholamine
metabolitesbetweenKIandWTmice,whichsuggests that thepe-
ripheral catecholamine level was not highly elevated in KI mice
(Figures S5A and S5B). Taken together, these findings suggested
that the increased energy expenditure in edited CAPS1 KI mice
could be attributed to increased physical activity, which was
most likely mediated through the central dopamine pathway.
Enhanced DCV-Mediated Catecholamine Secretion in
Edited CAPS1 KI Mice
Given that the secretion of catecholamines, including dopamine,
is mediated by DCVs, and that edited CAPS1 can facilitate the
release of NA more rapidly than unedited CAPS1 in PC12 cells
(Figure 2B), we further examined whether CAPS1 RNA editing
promoted DCV exocytosis in vivo. For this purpose, we first per-
formed amperometric measurements using chromaffin cells,
which demonstrated that the efficacy of vesicle exocytosis was
enhanced significantly during depolarizing stimulation in edited
CAPS1 KI mice (Figure 6A). Then, we measured intracellular
Ca2+ concentrations during the stimulation and found no signif-
icant difference between KI andWTmice (Figure 6B). The results
showed that increased Ca2+ influx did not cause the enhanced
exocytosis. Furthermore, we could not detect any significant
difference in adrenal catecholamine concentrations or the intra-
cellular distribution of DCVs (Figures 6C and 6D; Figures S6A
and S6B). Collectively, these findings suggest that the efficient
DCV exocytosis in chromaffin cells of edited CAPS1 KI mice is
achieved by most likely enhancing the priming step, but not
the loading or docking step, by RNA editing. Finally, we investi-
gated DCV-mediated secretion of catecholamines in neurons.
Synaptosomes were prepared from the striatum of KI and
WT mice, and the amount of radiolabeled dopamine that was
secreted during a depolarizing stimulation was quantified. The
results demonstrated that dopamine was secreted more effi-
ciently from neurons in KI mice than in WT mice (Figure 6E),
which further suggested that CAPS1 RNA editing promotes
DCV-mediated secretion of catecholamines in vivo.Cell Reports 17, 2004–2014, November 15, 2016 2007
Figure 3. Edited CAPS1 KI Mice Exhibit
Leanness
(A) The body weights of wild-type (WT; ten male
and nine female) and homozygous KI (KI; eight
male and ten female) mice were followed from 2 to
6 weeks after birth. The difference in sex distribu-
tion was not significant between the two groups
(p = 0.43, chi-square test).
(B and C) Body weight (B) and body length (C)
of male littermates of the WT and KI mice were
followed from 5 to 12 weeks after birth (see
Figure S3).
(D) The weights of various organs were compared
between male WT and KI mice. BAT, brown
adipose tissue; EWAT, epididymal white adipose
tissue.
(E) Plasma cholesterol levels of male WT and KI
mice are shown.
All data are presented as the mean ± SEM. Sta-
tistical differences were analyzed by the two-way
factorial ANOVA with Tukey HSD post hoc test
(A), multifactorial repeated-measures ANOVA with
Tukey HSD post hoc test (B and C), Mann–Whitney
test (D), and the unpaired t test (E) and are indi-
cated by asterisks (*p < 0.05, **p < 0.01). n.s., no
significance.EditedCAPS1BindsPreferentially to theActivated Form
of Syntaxin-1
Finally, we sought to elucidate the mechanism by which the edi-
ted CAPS1 enhances DCV exocytosis. It has been reported that
CAPS1 binds preferentially through its C-terminal region to the
‘‘open’’ conformation of syntaxin-1A, which is the activated
form, and that deletion of the C-terminal region, including the
E/G site, abolishes efficient NA secretion from PC12 cells (Grish-
anin et al., 2002; Hammarlund et al., 2008; Parsaud et al., 2013).
Therefore, we examined whether RNA editing affected the ability
of CAPS1 to bind syntaxin-1. First, we performed pull-down
assays using human CAPS1 tagged with HaloTag, which was
incubated with a mouse brain homogenate enriched with synap-
tosomal proteins. The data demonstrated that edited CAPS1
bound to syntaxin-1Amore efficiently than unedited CAPS1 (Fig-
ures 7A and 7B). We also compared the binding efficiency of
CAPS1 between constitutively ‘‘open’’ and ‘‘closed’’ conforma-
tions of syntaxin-1A by pull-down assays. This analysis showed
that although both edited and unedited CAPS1 bound the
‘‘open’’ conformation of syntaxin-1A significantly more efficiently
than the ‘‘closed’’ form, edited CAPS1 boundmore strongly than
the unedited protein to the former (Figures 7C and 7D). Taken
together, these results suggested that edited CAPS1 can bind
to the activated form of syntaxin-1 more efficiently than unedited
CAPS1, leading to enhancement of the priming step, which
could result in more efficient exocytosis.
DISCUSSION
The E/G site in CAPS1mRNA was identified initially as one of 55
editing sites in coding regions, by massive parallel sequencing
(Li et al., 2009). However, the effects of CAPS1 RNA editing2008 Cell Reports 17, 2004–2014, November 15, 2016have not been investigated previously, even in vitro. In the pre-
sent study, we identified the secondary structure required for
CAPS1 RNA editing and the enzymes responsible. We found
that CAPS1 RNA editing promotes catecholamine secretion
in cultured cells. Furthermore, we provide in vivo evidence
that CAPS1 RNA editing regulates physical activity, by using
mutant mice that express edited CAPS1 exclusively. These
mice exhibited increased locomotion and energy expenditure,
which could be attenuated by the suppression of the dopamine
pathway. These phenotypic features were attributable to
enhanced DCV exocytosis and contributed to the leanness of
the mutant mice. We found that DCV exocytosis was also upre-
gulated in the chromaffin cells of the adrenal gland in mutant
mice, which might contribute to the lean phenotype, in part.
The editing frequency of CAPS1 mRNA in mice tended to be
lower than that in humans, which is consistent with the much
higher level of RNA editing in primates than in mice. This higher
level is probably due to the presence ofAlu elements in primates,
which can be targeted preferentially by ADARs (Eisenberg et al.,
2005). However, given that the editing levels of the conserved
sites are largely preserved between human and mouse (Pinto
et al., 2014), the physiological significance of CAPS1 RNA edit-
ing might have increased in some selected tissues, such as the
adrenal gland, over the course of evolution. It is also a unique
feature that the editing frequency of CAPS1 mRNA is higher in
peripheral tissues than in neuronal tissues in human. Analysis
of the editing frequency in ADAR2/ mice suggested that
both ADAR1 and ADAR2 participated in CAPS1 RNA editing in
the brain. Indeed, coordinated regulation of RNA editing by
ADAR1 and ADAR2 is sometimes observed for certain sites,
such as the C and E sites in the neuron-specific 5-HT2C receptor
(Hartner et al., 2004). However, if ADAR2 is the main enzyme
Figure 4. Increased Energy Expenditure in
Edited CAPS1 KI Mice
(A) The metabolic rates of male littermates of wild-
type (WT) and homozygous KI (KI) mice were
measured by oxygen uptake (VO2) during a period
of 24 hr after habituation over 48 hr (left panel).
Then, the metabolic rates during both the dark
and light phases, as well as the total rates, were
compared between the two groups (right panel).
(B–F) Food intake (B), water intake (C), volume
of urine (D), UCP-1 mRNA levels in brown adi-
pose tissue (E), and body temperature (F) were
compared between WT and KI mice.
All data are presented as the mean ± SEM. Sta-
tistical differences were analyzed by the unpaired
t test (A–D) and Mann-Whitney test (E and F) and
are indicated by asterisks (*p < 0.05, **p < 0.01).
n.s., no significance.responsible for CAPS1 RNA editing, we would expect that the
editing frequency would bemuch higher in the brain than in other
tissues, given that ADAR2 is highly expressed in the brain
(Huntley et al., 2016). Considering that ADAR1 is ubiquitously
expressed, and the editing frequency was not altered in the pe-
ripheral tissues of ADAR2/ mice, we concluded that ADAR1
was probably the main enzyme responsible for CAPS1 RNA ed-
iting. Unfortunately, given that ADAR1/ mice die at embryonic
day (E) 11.5–12.5 (Wang et al., 2000) and that no editing of
CAPS1mRNA is detected at E15.5, it is impossible to investigate
how RNA editing is altered in ADAR1/ mice. It has recently
been reported that mutant mice that express inactive ADAR1
die at E13.5, whereas the lethality can be rescued by concurrent
deletion of a cytosolic sensor of dsRNA, MDA5, after which
the mice can survive until adulthood (Liddicoat et al., 2015).
Therefore, future analyses of these double mutant mice could
determine whether ADAR1 is the major enzyme responsible.
The role of the C-terminal region of CAPS1 in exocytosis,
especially in the priming step, remains controversial. The region
that contains the E/G site was identified originally as a domain
required for the association with DCVs (Grishanin et al., 2002).
Subsequently, the C-terminal region that encompasses MDH1
(Munc13-homology domain) and DCVBD has been reported
to bind to SNARE proteins and to promote SNARE-mediated
vesicle fusion (Hammarlund et al., 2008; James et al., 2009;
Parsaud et al., 2013). In contrast, a recent study demonstratedC-
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located in the middle of CAPS1, but
not the C-terminal region, is essential
for the priming of secretory vesicles by
CAPS1 (Nguyen Truong et al., 2014).
However, the present study demon-
strated that a single point mutation
in the DCVBD, leading to the exclu-
sive expression of edited CAPS1,
induced leanness and hyperactivity in
mice. Furthermore, DCV exocytosis was
enhanced in these mutant mice, which
indicated that the E/G site-containingterminal region was physiologically significant and critical
r exocytosis.
The edited CAPS1 KI mice exhibited increased physical activ-
, which was attenuated by the administration of the dopamine
receptor antagonist. We further demonstrated that synapto-
mes derived from these mutant mice could secrete dopamine
ore efficiently than those from WT mice. Intriguingly, mutant
ice that lack the dopamine transporter also exhibit a greater
gree of hyperactivity and leanness (Giros et al., 1996), which
ggests that the hyperactivity of the edited CAPS1 KI mice is
ediated predominantly through the dopamine pathway. The
tent to which CAPS1 RNA editing controls physical activity
humans and the WT mouse, in which 10%–20% of brain
PS1 is edited, remains to be determined. It is possible that
e editing frequency is higher in certain subtypes of neurons
the editing is dynamically regulated among individual neurons.
rthermore, it has been reported that the priming step of
naptic vesicle exocytosis is downregulated in the hippocam-
l glutamargic neurons of CAPS1 KO mice, although it remains
known whether this affects physical activity (Jockusch et al.,
07). Consequently, further investigation is needed to elucidate
e differences in editing frequency at the single cell level
d to determine whether CAPS1 RNA editing modulates
e exocytosis of synaptic vesicles in addition to DCVs.
Of note, the CAPS family is known to be involved in develop-
ental disorders that affect physical activity. The locus of thes 17, 2004–2014, November 15, 2016 2009
Figure 5. Edited CAPS1 KI Mice Exhibit
Increased Physical Activity
(A and B) Open-field tests (A) and circadian rhythm
tests (B) were performed over the indicated time
periods for male littermates of wild-type (WT) and
homozygous KI (KI) mice (left panels). Then, the
locomotion count (A) and the activity count (B)
over the indicated time periods were compared
between the two groups (right panels).
(C) Either haloperidol (Hlp; 0.5 mg/kg) or saline
(vehicle) was injected intraperitoneally 1 hr after the
dark cycle had started (indicated with an arrow on
left panel). After waiting for an additional 1 hr, total
activity during each hour was measured for the
subsequent 10 hr and compared between WT and
KI mice (right panel).
(D) Either haloperidol (Hlp; 0.5 mg/kg) or saline
(vehicle) was injected intraperitoneally 1 hr after the
dark phase had started. After waiting for an addi-
tional 1 hr, metabolic rates during each hour were
measured for the subsequent 10 hr and compared
between WT and KI mice. See also Figures S4
and S5.
All data were acquired from the indicated numbers
of male mice and are presented as the mean ±
SEM. Statistical differences were analyzed by
multifactorial repeated-measures ANOVA with
Tukey HSD post hoc tests (A), unpaired t tests (B),
and one-way ANOVA with Tukey HSD post hoc
tests (C and D) and are indicated by asterisks (*p <
0.05, **p < 0.01). n.s., no significance.CADPS2 gene, which encodes CAPS2, is located within the
autism susceptibility locus 1 (AUTS1) (International Molecular
Genetic Study of Autism Consortium, 2001), and it is reported
to be mutated in patients with intellectual disability (Bailey
et al., 1998). CAPS2/ mice exhibit autistic-like phenotypes,
including reduced activity in an open field in the presence of a
novel object (Sadakata et al., 2007). Furthermore, a recent study
reported a case of a proximal interstitial deletion of chromosome
3p that includes the CADPS gene locus (de la Hoz et al., 2015).
Although it is unclear whether physical activity is affected, the
deletion results in speech and social interaction difficulties and
learning disability. These findings imply that dysregulation of
CAPS1 RNA editing might be involved in some disorders that
affect physical activity, and this requires further investigation.
EXPERIMENTAL PROCEDURES
Please see Supplemental Experimental Procedures for the full experimental
procedures.
Mouse Administration
Mice were maintained on a 12-hr-light/dark cycle at a temperature of 23C ±
1.5Cwith a humidity of 45%± 15%. All experimental procedures that involved2010 Cell Reports 17, 2004–2014, November 15, 2016mice were approved by the Institutional Animal
Care and Use Committee of Osaka University and
Institutional Animal Care and RIKEN Kobe Branch.
Generation of Edited CAPS1 KI Mice
The mutant mice carrying glycine at the
E/G site in CAPS1 (accession numberCDB1091K: http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) were
generated as described (Yagi et al., 1993) using TT2 embryonic stem (ES) cells
that were derived from an F1 embryo between C57BL/6 and CBA (http://www.
clst.riken.jp/arg/Methods.html). To generate a targeting vector, genomic
fragments of the Cadps locus that contained the exon containing the E/G site
were obtained from the RP23-466K8 BAC clone (BACPAC Resources) and in-
serted into the DT-A-pA/loxP/PGK-Neo-pA/loxP vector (http://www.clst.riken.
jp/arg/cassette.html). An adenine-to-guanine substitution was introduced
by site-directed mutagenesis so that the codon for glutamic acid (GAG) at
the E/G site was replaced by one for glycine (GGG). Targeted ES clones were
microinjected into ICR 8-cell stage embryos, and the injected embryos were
transferred into pseudopregnant ICR females. The resulting chimeras were
bred with C57BL/6 mice, and the germline transmission to heterozygous
offspring was confirmed by Southern blotting using probes that targeted the
positions indicated in Figure S3A and also by PCR. Then, the mutant mice
were backcrossed with C57BL/6 mice more than six times for phenotypic
analyses. Genotyping was performed by direct sequencing of PCR products
that contained the E/G site using the sequencing primer mCAPS1-KI-Dw1
(50-AGAGGGAGAGGAGAGATTC-30). PCR products (306 bp) were amplified
with the following primers: mCAPS1-KI-Fw1 (50-ACTTTCGTCCGCCATT
CTC-30) and mCAPS1-KI-Dw2 (50-CGTCCACATATCACACAGACT-30).
In Vitro RNA Editing Assay for Human CAPS1 Pre-mRNA
The in vitro editing assay was performed as described previously (Kawahara
et al., 2007b). In brief, the in vitro editing reaction mixture, which contained
Figure 6. Increased DCV Exocytosis in
Edited CAPS1 KI Mice
(A) Representative traces of amperometric mea-
surements from individual chromaffin cells (left
panel). Exocytosis was triggered during the
period indicated by the black bars. Exocytotic
responses were compared between wild-type
(WT) and homozygous KI (KI) mice by measuring
the total area under the curve during stimulation
(right panel). All data were acquired from 18 and
21 cells isolated from three mice of the WT and
KI, respectively.
(B) Representative traces of the measurements
of the intracellular calcium concentration from
individual chromaffin cells (left panel). KCl was
applied during the period indicated by the black
bars. The calcium influx was compared between
WT and KI mice by subtracting the basal calcium
concentration from the peak (right panel). All data
were acquired from 16 and 19 cells isolated from
three mice of the WT and KI, respectively.
(C) The concentration of three catecholamines
in adrenal glands was compared between WT and
KI mice (n = 4 for each group).
(D) The distribution of whole DCVs in individual
chromaffin cells as determined from the electron
microscopy images (see Figure S6). All data
were acquired from a total of 48 cells from five
WT mice and 49 cells from five KI mice.
(E) Dopamine secretion from synaptosomes
derived from the striatum was measured every
3 min after stimulation with high K+ buffer (30K)
and is shown as a percentage relative to the basal
release, which is set as 100%. NS, no stimulation.
All data are presented as the mean ± SEM. Sta-
tistical differences were analyzed by unpaired
t tests (A–D) and Mann-Whitney tests (E) and
are indicated by asterisks (*p < 0.05). n.s., no
significance.5 fmol of synthesized RNA and the indicated amount of recombinant
ADAR1 or ADAR2 protein (Figure S1C), was incubated at 30C for 1 hr. Then,
the samples were treated with 2 3 Proteinase K buffer (100 mM Tris-HCl
[pH 7.5], 100 mMNaCl, and 20 mMMgCl2) that contained 2 mg/mL Proteinase
K (Ambion) at 55C for 30 min, and the RNA fragments were recovered by
phenol extraction and 2-propanol precipitation with glycogen. After treatment
withDNase I, thedenaturedRNAsweresubjected toRT-PCR followedbydirect
sequencing. The editing frequency was determined as the % ratio of the ‘‘G’’
peak over the sum of the ‘‘G’’ and ‘‘A’’ peaks of the sequencing chromatogram.
[3H]NA Release Assays Using PC12 Cells
The release of [3H]NA was quantified as described previously with minor mod-
ifications (Parsaud et al., 2013). In brief, 2.0 3 105 shRNA_All-8 PC12-derived
cells expressing either unedited or edited mCAPS1 stably were incubated
in a 24-well plate with 1.0 mCi/mL [3H]NA (levo-[7-3H]-Norepinephrine;
PerkinElmer) in the presence of 0.5 mM ascorbic acid for 16 hr. The radiola-
beled cells were incubated with fresh DMEM for 5 hr to remove unincorporated
[3H]NA. After the cells had been washed once with 200 ml of PSS buffer
(145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose,
and 15 mM HEPES [pH 7.4]), NA secretion was induced by incubation at
37C in 200 ml of high K+ buffer 1 (HK1; 81 mM NaCl, 70 mM KCl, 2.2 mM
CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES [pH 7.4]) for 15,30, or 60 min. Then, the supernatant was removed immediately and collected
into a 1.5-mL tube. The resultant pellets were lysed with 500 ml of 0.1% Triton
X-100. Both the supernatant and the cell lysate (140 ml each) were mixed with
700 ml of MicroScint-20 cocktail (PerkinElmer), and the b activity derived from
[3H] was quantified using a liquid scintillation counter (Micro Beta2 Plate
Counter; PerkinElmer). The efficiency of [3H]NA release was calculated by
dividing the amount of [3H]NA in the supernatant by the total amount of [3H]
NA present in both the supernatant and the cells.
Metabolic Rate
The rate of oxygen consumption was measured by indirect calorimetry using a
small animal metabolic measurement system (MK-5000RQ; Muromachi). An
individual adult male mouse (9–14 weeks of age) was placed in the chamber
under standard feeding conditions. After habituation over a period of 48 hr,
the oxygen consumption rate was measured every 3 min for 24 hr. To evaluate
the effect of haloperidol, a dopamine D2 receptor antagonist, on physical ac-
tivity, an individual adult male mouse (9–20 weeks of age) was placed in the
chamber as well. Then, either 0.5 mg/kg haloperidol (Sigma-Aldrich) dissolved
in saline or an equal volume of saline (control) was injected intraperitoneally
1 hr after the dark cycle had started, while the rate of oxygen consumption
was being measured. After waiting for an additional 1 hr, the oxygen con-
sumption rate was measured for the subsequent 10 hr.Cell Reports 17, 2004–2014, November 15, 2016 2011
Figure 7. RNA Editing Promotes the Binding
of CAPS1 to the Activated Form of Syn-
taxin-1A
(A) The amount of endogenous syntaxin-1A in
mouse brain homogenate that bound to either
unedited or edited Halo-human CAPS1 in pull-
down assays was analyzed by western blotting.
The expression level of CAPS1 is shown as
a reference.
(B) The relative amount of endogenous syntaxin-1A
bound to CAPS1 was compared between the
unedited and edited isoforms. Values are dis-
played as the mean ± SEM (n = 3; Mann-Whitney
test, *p < 0.05).
(C) The amount of syntaxin-1A in either the closed
(Cl) or open (Op) conformation that bound to either
unedited or edited Halo-human CAPS1 in pull-
down (IP) assays was analyzed by western blot-
ting. The expression of CAPS1 is shown as a
reference.
(D) The relative amount of syntaxin-1A in either the
closed (Cl) or open (Op) conformation bound to
either unedited or edited CAPS1 was compared.
All values are displayed as the mean ± SEM (n = 6;
one-way ANOVA with Wilcoxon test, *p < 0.05).
The mean value of the relative amount of closed
conformation syntaxin-1A bound to unedited
CAPS1 was set as one.Behavioral Analyses
All the behavioral analyses were performedwith the same groups of adult male
littermates of WT and homozygous KI mice (11–19 weeks of age) by inserting
an adequate time period between each test.
Open-Field Tests
The open-field test was conducted as described previously (Taniguchi et al.,
2005). A cubic box made of transparent acrylic plates (30 3 30 3 30 cm)
without a ceiling was housed in a ventilated soundproof chamber. An overhead
incandescent light bulb provided room lighting that measured approximately
110 lux at the center of the test arena. In addition, a fan attached to the upper
part of the wall at one end of the chamber provided a masking noise of 45 dB
inside the chamber. On each X and Y lateral side of the open-field box, two
infrared beams were attached 2 cm above the floor at a distance of 10 cm
apart. A flip-flop circuit was set up between the two beams. The total number
of circuit breaks was taken as ameasure of locomotive behavior. Animals were
allowed to explore freely in the open-field arena for 10 min.
Circadian Rhythm Tests
Circadian rhythm tests were conducted using a cubic box (45 3 45 3 45 cm)
equippedwith an infrared sensor on the ceiling. Eachmousewas placed inside
the box 5 hr after the start of the light cycle. After 9 hr of rest, the activity of the
mousewas quantified by the infrared sensor every 1 s for 24 hr. To evaluate the
effect of haloperidol, a dopamine D2 receptor antagonist, on physical activity,
either 0.5 mg/kg haloperidol dissolved in saline or an equal volume of saline
(control) was injected intraperitoneally 1 hr after the dark cycle had started. Af-
ter waiting for an additional 1 hr, the total activity during each hour was deter-
mined for the subsequent 10 hr.
Amperometric Detection
Catecholamine release from each individual adrenal chromaffin cell was
measured by amperometric recording as described previously (Ohta et al.,
2010). The coverslip with an attached chromaffin cell was placed in the
recording chamber mounted on the stage of an inverted microscope (Diaphot
300; Nikon). Cells were superfused at a flow rate of 2 mL/min with standard
external buffer (134 mMNaCl, 6 mM KCl, 1.2 mMMgCl2, 2.5 mMCaCl2, 5 mM
glucose, and 10 mM HEPES [pH 7.4]). The tip of the carbon fiber electrode
(ProCFE; Dagan) was advanced gently to touch the surface of the chromaffin2012 Cell Reports 17, 2004–2014, November 15, 2016cell of interest using a micromanipulator (MHW-3; Narishige). The +600 mV
was applied to the electrode under voltage-clamp conditions. The currents
that resulted from the oxidation of catecholamines were recorded using
an electrochemical detector (CHEM-CLAMP; Dagan). The data on the
currents were digitized and analyzed using an A/D converter (PowerLab;
AD Instruments) in conjunction with a personal computer. The recorded
amperometric currents reflect vesicles that have been released close to
the electrode and represent the fusion of exocytotic vesicles with the cell
membrane. The responsiveness of the carbon fiber electrodes to catechol-
amine was examined before the experiment using 5 mM adrenaline (Daiichi
Sankyo). High K+-induced changes in the amperometric current (Iamp) and
the total charge were assessed by calculating the area under the curve
(a time-integral; AUC) during the application of high K+ buffer 2 (HK2; 70 mM
KCl, 70 mM NaCl, 1.2 mM MgCl2, 2.5 mM CaCl2, 5 mM glucose, and 10 mM
HEPES [pH 7.4], with NaOH). All experiments were carried out at room
temperature.
Measurement of Intracellular Ca2+ Concentration
The intracellular Ca2+ concentration ([Ca2+]i) in each individual chromaffin cell
was measured with the fluorescent Ca2+ indicator fura-2 by dual excitation,
using a fluorescence-imaging system with controlled illumination and acquisi-
tion (Aqua Cosmos; Hamamatsu Photonics). After the cells had been incu-
bated for 40 min at 37C with 10 mM fura-2 AM (Molecular Probes) in standard
external solution, a coverslip with fura-2-loaded cells was placed in an exper-
imental chamber that was mounted on the stage of an inverted microscope
(IX71; Olympus) equipped with an image acquisition and analysis system
(Aqua Cosmos). Cells were illuminated every 5 s with light at 340 and
380 nm, and the respective fluorescence signals at 500 nm were detected.
The fluorescence emitted was projected onto a charge-coupled device
camera (ORCA-ER; Hamamatsu Photonics), and the ratios of the fluorescent
signals (F340/F380) for [Ca2+]i were stored on the hard disk of a personal
computer.
Ultrastructural Analyses
After overnight fasting, adult male mice (9 weeks of age) were anesthetized by
intraperitoneal injection of a mixture of 0.3 mg/kg medetomidine, 4 mg/kg
midazolam, and 5 mg/kg butorphanol. After perfusion of the fixing solution
(2% glutaraldehyde and 2% paraformaldehyde), the adrenal gland was
dissected and incubated in the fixing solution for 2 hr. Sections were prepared
at the National Institute of Biomedical Innovation, Osaka, Japan, as follows.
The sample was incubated in 2% osmium acid (Merck) for 1 hr at 4C and
then dehydrated with a graded series of ethanol (50%–100%) and QY-1
(Nisshin EM). The fixed adrenal gland was embedded in EPON812 (TAAB
Laboratories Equipment) and incubated at 60C for 1 hr and at 80C for
an additional 48 hr. Then, the embedded samples were sectioned on an
ultramicrotome (EMUC6; Leica) at a thickness of 60 nm andmounted on grids.
The sections were stained with uranyl acetate (Electron Microscopy Science)
for 30 min and with lead stain solution (Lead citrate EM, Lead nitrate EM,
and Lead acetate EM; TAAB Laboratories Equipment) for 10 min. Images
were obtained using a transmission electron microscope (JEM-1400 plus;
JEOL) at an acceleration voltage of 80 kV. The distribution of DCVs was
measured as described previously with modifications (de Wit et al., 2009;
Hammarlund et al., 2008; Liu et al., 2008). In brief, multiple digital images taken
at 20,000 3 magnification were merged using Microsoft ICE software (http://
research.microsoft.com/en-us/um/redmond/projects/ice/) to cover the entire
area of each cell. Then, the distance from the plasma membrane to the mem-
brane of each granule that had a round, dense core, and a diameter of more
than 40 nm was measured in each individual cell using ImageJ software
(http://rsb.info.nih.gov/ij/).
Dopamine Release Tests
Dopamine release tests were conducted as described previously with modifi-
cations (Grady et al., 1992; Narboux-Ne^me et al., 2011). Synaptosomes pre-
pared from mouse brain striatum were incubated in 200 ml of the perfusion
buffer with 0.1 mM [3H]DA (3,4-[ring-2,5,6-3H]-dopamine; PerkinElmer) for
10 min at 37C and centrifuged at 6,000 3 g for 10 min at room temperature.
The synaptosomal pellet was resuspended in 200 ml of the perfusion buffer and
incubated for 10 min. Then, 100 ml of the synaptosomal suspension were
loaded on a glass filter (grade GF/B; GE Healthcare) that had been fixed in a
3-piece filter funnel (GE Healthcare). The filter had been prewashed by loading
500 ml of the perfusion buffer onto the glass filter and vacuum filtering after in-
cubation for 3 min; this was repeated six times. After loading of the synapto-
somal suspension, 500 ml of the perfusion buffer were loaded onto the glass
filter and vacuum filtered after incubation for 3 min. Then, an additional
1,500 ml of the perfusion buffer were loaded and vacuum filtered immediately.
As a result, the [3H]DA released from the synaptosomes during the 3-min incu-
bation was collected in a volume of 2,000 ml. Subsequently, 500 ml of either
high K+ buffer 3 (HK3; 100.4 mM NaCl, 30.0 mM KCl, 3.2 mM CaCl2, 1.2 mM
MgSO4, 25.0 mM HEPES [pH 7.4], 10.0 mM glucose, 1.0 mM ascorbate,
and 0.01mMpargyline) or the perfusion buffer was loaded and vacuum filtered
after incubation for 3 min. Then, an additional 1,500 ml of HK3 or the perfusion
buffer were loaded and vacuum filtered immediately. This procedure was
repeated every 3 min three times. Finally, 200 ml of each filtrate was mixed
with 800 ml of MicroScint-20 cocktail, and the b activity derived from [3H]
was quantified by using liquid scintillation counting.
Statistical Analyses
The chi-square test, one-way ANOVA, two-way ANOVA, multifactorial
repeated-measures ANOVA, Mann–Whitney test, or the unpaired t test was
used as described in each figure legend. All p values were two sided. Statisti-
cal significance was set at *p < 0.05 and **p < 0.01.
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